Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maspero

Showing results (461-470 of 536) with videos related to

Pageof 54
Sort By:
Physics in Medicine and Biology|November 8, 2019
Soft-tissue prostate intrafraction motion tracking in 3D cine-MR for MR-guided radiotherapyD M de Muinck Keizer, L G W Kerkmeijer, M Maspero, et al.
The Journal of Allergy and Clinical Immunology|January 10, 2022
Mepolizumab for chronic rhinosinusitis with nasal polyps: Treatment efficacy by comorbidity and blood eosinophil countClaus Bachert, Ana R Sousa, Joseph K Han, et al.
Lancet (London, England)|May 1, 2016
Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trialSally Wenzel, Mario Castro, Jonathan Corren, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 10, 2022
Dupilumab Efficacy in Steroid-Dependent Severe Asthma by Baseline Oral Corticosteroid DoseChristian Domingo, Jorge F Maspero, Mario Castro, et al.
The Journal of Allergy and Clinical Immunology|January 25, 2024
Blood eosinophils and fractional exhaled nitric oxide are prognostic and predictive biomarkers in childhood asthmaLeonard B Bacharier, Ian D Pavord, Jorge F Maspero, et al.
Journal of Asthma and Allergy|March 14, 2023
Dupilumab Efficacy in Patients with Uncontrolled Moderate-to-Severe Type 2 Asthma Regardless of Perennial Aeroallergen SensitizationJonathan Corren, David J Jackson, Thomas B Casale, et al.
The Lancet. Respiratory Medicine|October 7, 2021
Oral corticosteroid elimination via a personalised reduction algorithm in adults with severe, eosinophilic asthma treated with benralizumab (PONENTE): a multicentre, open-label, single-arm studyAndrew Menzies-Gow, Mark Gurnell, Liam G Heaney, et al.
EMBO Molecular Medicine|December 23, 2016
HUWE1 is a critical colonic tumour suppressor gene that prevents MYC signalling, DNA damage accumulation and tumour initiationKevin B Myant, Patrizia Cammareri, Michael C Hodder, et al.
Physics and Imaging in Radiation Oncology|November 6, 2024
Automatic segmentation for magnetic resonance imaging guided individual elective lymph node irradiation in head and neck cancer patientsFloris C J Reinders, Mark H F Savenije, Mischa de Ridder, et al.
Advances in Therapy|May 5, 2018
Liberty Asthma QUEST: Phase 3 Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate Dupilumab Efficacy/Safety in Patients with Uncontrolled, Moderate-to-Severe AsthmaWilliam W Busse, Jorge F Maspero, Klaus F Rabe, et al.
Pageof 54

Showing results (461-470 of 536) with videos related to

Sort By:
Pageof 54
Physics in Medicine and Biology|November 8, 2019
Soft-tissue prostate intrafraction motion tracking in 3D cine-MR for MR-guided radiotherapyD M de Muinck Keizer, L G W Kerkmeijer, M Maspero, et al.
The Journal of Allergy and Clinical Immunology|January 10, 2022
Mepolizumab for chronic rhinosinusitis with nasal polyps: Treatment efficacy by comorbidity and blood eosinophil countClaus Bachert, Ana R Sousa, Joseph K Han, et al.
Lancet (London, England)|May 1, 2016
Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trialSally Wenzel, Mario Castro, Jonathan Corren, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 10, 2022
Dupilumab Efficacy in Steroid-Dependent Severe Asthma by Baseline Oral Corticosteroid DoseChristian Domingo, Jorge F Maspero, Mario Castro, et al.
The Journal of Allergy and Clinical Immunology|January 25, 2024
Blood eosinophils and fractional exhaled nitric oxide are prognostic and predictive biomarkers in childhood asthmaLeonard B Bacharier, Ian D Pavord, Jorge F Maspero, et al.
Journal of Asthma and Allergy|March 14, 2023
Dupilumab Efficacy in Patients with Uncontrolled Moderate-to-Severe Type 2 Asthma Regardless of Perennial Aeroallergen SensitizationJonathan Corren, David J Jackson, Thomas B Casale, et al.
The Lancet. Respiratory Medicine|October 7, 2021
Oral corticosteroid elimination via a personalised reduction algorithm in adults with severe, eosinophilic asthma treated with benralizumab (PONENTE): a multicentre, open-label, single-arm studyAndrew Menzies-Gow, Mark Gurnell, Liam G Heaney, et al.
EMBO Molecular Medicine|December 23, 2016
HUWE1 is a critical colonic tumour suppressor gene that prevents MYC signalling, DNA damage accumulation and tumour initiationKevin B Myant, Patrizia Cammareri, Michael C Hodder, et al.
Physics and Imaging in Radiation Oncology|November 6, 2024
Automatic segmentation for magnetic resonance imaging guided individual elective lymph node irradiation in head and neck cancer patientsFloris C J Reinders, Mark H F Savenije, Mischa de Ridder, et al.
Advances in Therapy|May 5, 2018
Liberty Asthma QUEST: Phase 3 Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate Dupilumab Efficacy/Safety in Patients with Uncontrolled, Moderate-to-Severe AsthmaWilliam W Busse, Jorge F Maspero, Klaus F Rabe, et al.
Pageof 54